AML With Myelodysplasia-related Features - 27 Studies Found

Terminated : Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2011-10-10
    : Drug: bortezomib Given SC Other Names:
Completed : Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2011-05-06
    :
    • Drug: alvocidib Given IV
Completed : Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2010-03-24
    :
    • Procedure: double-unit umbilical cord blood transplantation

Completed : Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2008-11-20
    :
    • Drug: alvocidib Given IV
Completed : Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2008-01-19
    :
    • Drug: tipifarnib Given orally
Completed : Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2006-05-30
    :
    • Drug: vorinostat Given orally
Completed : Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2006-05-02
    :
    • Radiation: total-body irradiation

Completed : Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2005-01-07
    :
    • Drug: tipifarnib Given orally
Active, not recruiting : Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2002-09-06
    :
    • Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantati
Completed : Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • : 2001-12-07
    :
    • Drug: tipifarnib Given orally
<<< Previous | Next >>>